Literature DB >> 21659521

Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I).

Marco Binder1, Florian Eberle, Stefan Seitz, Norbert Mücke, Christian M Hüber, Narsis Kiani, Lars Kaderali, Volker Lohmann, Alexander Dalpke, Ralf Bartenschlager.   

Abstract

RIG-I is a major innate immune sensor for viral infection, triggering an interferon (IFN)-mediated antiviral response upon cytosolic detection of viral RNA. Double-strandedness and 5'-terminal triphosphates were identified as motifs required to elicit optimal immunological signaling. However, very little is known about the response dynamics of the RIG-I pathway, which is crucial for the ability of the cell to react to diverse classes of viral RNA while maintaining self-tolerance. In the present study, we addressed the molecular mechanism of RIG-I signal detection and its translation into pathway activation. By employing highly quantitative methods, we could establish the length of the double-stranded RNA (dsRNA) to be the most critical determinant of response strength. Size exclusion chromatography and direct visualization in scanning force microscopy suggested that this was due to cooperative oligomerization of RIG-I along dsRNA. The initiation efficiency of this oligomerization process critically depended on the presence of high affinity motifs, like a 5'-triphosphate. It is noteworthy that for dsRNA longer than 200 bp, internal initiation could effectively compensate for a lack of terminal triphosphates. In summary, our data demonstrate a very flexible response behavior of the RIG-I pathway, in which sensing and integration of at least two distinct signals, initiation efficiency and double strand length, allow the host cell to mount an antiviral response that is tightly adjusted to the type of the detected signal, such as viral genomes, replication intermediates, or small by-products.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659521      PMCID: PMC3149321          DOI: 10.1074/jbc.M111.256974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

2.  5'-Triphosphate RNA is the ligand for RIG-I.

Authors:  Veit Hornung; Jana Ellegast; Sarah Kim; Krzysztof Brzózka; Andreas Jung; Hiroki Kato; Hendrik Poeck; Shizuo Akira; Karl-Klaus Conzelmann; Martin Schlee; Stefan Endres; Gunther Hartmann
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

3.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

Review 4.  Function of RIG-I-like receptors in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

5.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

6.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

7.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.

Authors:  Yueh-Ming Loo; David M Owen; Kui Li; Andrea K Erickson; Cynthia L Johnson; Penny M Fish; D Spencer Carney; Ting Wang; Hisashi Ishida; Mitsutoshi Yoneyama; Takashi Fujita; Takeshi Saito; William M Lee; Curt H Hagedorn; Daryl T-Y Lau; Steven A Weinman; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.

Authors:  Marco Binder; Georg Kochs; Ralf Bartenschlager; Volker Lohmann
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

9.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

10.  Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5' triphosphate.

Authors:  Cheng Lu; C T Ranjith-Kumar; Lujiang Hao; C Cheng Kao; Pingwei Li
Journal:  Nucleic Acids Res       Date:  2010-10-20       Impact factor: 16.971

View more
  69 in total

1.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.

Authors:  Alys Peisley; Cecilie Lin; Bin Wu; McGhee Orme-Johnson; Mengyuan Liu; Thomas Walz; Sun Hur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Structural basis of RNA recognition and activation by innate immune receptor RIG-I.

Authors:  Fuguo Jiang; Anand Ramanathan; Matthew T Miller; Guo-Qing Tang; Michael Gale; Smita S Patel; Joseph Marcotrigiano
Journal:  Nature       Date:  2011-09-25       Impact factor: 49.962

3.  PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin.

Authors:  Jianzhong Zhu; Carolyn B Coyne; Saumendra N Sarkar
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

4.  MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA.

Authors:  Ian C Berke; Yorgo Modis
Journal:  EMBO J       Date:  2012-02-07       Impact factor: 11.598

Review 5.  Architecture and biogenesis of plus-strand RNA virus replication factories.

Authors:  David Paul; Ralf Bartenschlager
Journal:  World J Virol       Date:  2013-05-12

6.  Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Authors:  Shridhar Bale; Jean-Philippe Julien; Zachary A Bornholdt; Alexander S Krois; Ian A Wilson; Erica Ollmann Saphire
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

7.  ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.

Authors:  Jenish R Patel; Ankur Jain; Yi-ying Chou; Alina Baum; Taekjip Ha; Adolfo García-Sastre
Journal:  EMBO Rep       Date:  2013-07-12       Impact factor: 8.807

8.  Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH.

Authors:  Markus Kainulainen; Matthias Habjan; Philipp Hubel; Laura Busch; Simone Lau; Jacques Colinge; Giulio Superti-Furga; Andreas Pichlmair; Friedemann Weber
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

9.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

10.  The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection.

Authors:  Anand Ramanathan; Swapnil C Devarkar; Fuguo Jiang; Matthew T Miller; Abdul G Khan; Joseph Marcotrigiano; Smita S Patel
Journal:  Nucleic Acids Res       Date:  2015-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.